Stockscreener 앱 받기
0.00
100.00%
-11.00
Evoke Pharma Inc 주식(EVOK)의 최신 뉴스
Market Recap: Is Artivion Inc stock undervalued right now2025 Technical Patterns & Technical Pattern Alert System - baoquankhu1.vn
Gastroparesis Treatment Market 2026-2033: Growth Overview, - openPR.com
Income Plays: What is Evoke Pharma Incs 5 year growth outlook2025 Volatility Report & Verified Short-Term Plans - baoquankhu1.vn
Can Evoke Pharma Inc. continue delivering strong returnsCPI Data & High Conviction Investment Ideas - mfd.ru
How cyclical is Evoke Pharma Inc.’s revenue streamQuarterly Performance Summary & Consistent Return Strategy Ideas - mfd.ru
Institution Moves: Can Evoke Pharma Inc grow without dilutionWeekly Investment Summary & Verified Swing Trading Watchlist - baoquankhu1.vn
Moving Averages: Is Evoke Pharma Inc a speculative investment2025 Valuation Update & Consistent Growth Stock Picks - baoquankhu1.vn
Is Evoke Pharma Inc.’s ROE strong enoughWeekly Trade Summary & Weekly Chart Analysis and Guides - bollywoodhelpline.com
IPO Launch: Is Evoke Pharma Inc stock heavily shortedJuly 2025 Fed Impact & Low Risk Entry Point Guides - baoquankhu1.vn
Evoke Pharma Leads Stock Performance with 149.43% Return Over Past Year - Markets Mojo
Evoke Pharma Achieves 313.53% Return, Leading Recent Stock Performers - Markets Mojo
Is Evoke Pharma Inc. a speculative investmentEarnings Risk Report & Fast Gaining Stock Strategy Reports - bollywoodhelpline.com
Evoke Pharma (NASDAQ:EVOK) Stock Price Passes Above 50 Day Moving Average – Time to Sell? - Defense World
US Market Wrap: What are analysts price targets for Evoke Pharma Inc2025 Fundamental Recap & Low Risk Entry Point Guides - baoquankhu1.vn
AI Stocks: Is Evoke Pharma Inc a speculative investmentJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Wall Street Recap: Will Evoke Pharma Inc benefit from seasonalityJuly 2025 PostEarnings & Low Risk Entry Point Guides - baoquankhu1.vn
Evoke Pharma Leads Micro-Cap Stocks with 137.07% Return Over Past Year - Markets Mojo
Evoke Pharma Leads Micro-Cap Stocks with 149.43% Return Over Past Year - MarketsMojo
Evoke Pharma Achieves 304.41% Return, Leading Micro-Cap Stock Performance - MarketsMojo
Will Evoke Pharma Inc. stock benefit from commodity prices2025 AllTime Highs & Low Risk High Win Rate Picks - Улправда
How The Story Behind Evoke (LSE:EVOK) Is Changing With Takeover Terms And UK Gaming Tax - Yahoo Finance
Evoke Pharma Achieves 313.53% Return Amid Mixed Micro-Cap Performance - Markets Mojo
What technical charts say about Evoke Pharma Inc. stock - ulpravda.ru
Will Evoke Pharma Inc. stock keep outperforming rivalsJuly 2025 Fed Impact & Daily Risk Controlled Trade Plans - Улправда
Will Evoke Pharma Inc. stock gain from strong economyWeekly Profit Analysis & High Accuracy Trade Alerts - ulpravda.ru
Why Evoke Pharma Inc. stock is considered a top pickEarnings Trend Report & Fast Entry High Yield Stock Tips - Улправда
How Evoke Pharma Inc. stock performs in rate cut cyclesWeekly Trade Summary & Capital Efficiency Focused Strategies - Улправда
How Evoke Pharma Inc. stock performs in stagflationTrade Analysis Report & Stepwise Swing Trade Plans - ulpravda.ru
Evoke Pharma, Inc.Common Stock (NQ: EVOK - FinancialContent
How Evoke Pharma Inc. stock performs after earningsSwing Trading Watchlist & Free Strong Return On Assets - ulpravda.ru
Evoke Pharma Leads Pharmaceuticals Sector with 137.07% Annual Return - Markets Mojo
Operating cash flow per share of Evoke Pharma, Inc. – SWB:EV0 - TradingView — Track All Markets
Evoke Pharma Achieves 304.41% Return Amid Strong Market Performance - Markets Mojo
Evoke Pharma Achieves 313.53% Return; InnovAge Holding Up 31.39% - Markets Mojo
Evoke Pharma Achieves 313.53% Return Amid Market Volatility - Markets Mojo
Evoke Pharma Leads with 124.95% Return Among Notable Stock Performers - Markets Mojo
Evoke Pharma Leads Stock Performance with 148.87% Return in Pharmaceuticals Sector - Markets Mojo
Evoke Pharma Leads with 148.87% Return Among High-Performing Stocks - Markets Mojo
Bank Watch: Will Evoke Pharma Inc stock gain from strong economyQuarterly Earnings Report & Smart Allocation Stock Reports - moha.gov.vn
Evoke Pharma Leads Impressive Stock Returns with 126.34% Gain - Markets Mojo
Evoke Pharma Achieves 318.7% Return, Leading Pharmaceutical Stocks Performance - Markets Mojo
Evoke Pharma Leads Six-Month Stock Returns with 316.67% Gain - Markets Mojo
Evoke Pharma Achieves 316.67% Return, Leading Pharmaceutical Sector Performance - Markets Mojo
Evoke Pharma, Inc. Financial Disclosures & Filings - TradingView — Track All Markets
Evoke Pharma Leads Stocks with 124.49% Return in Pharmaceuticals Sector - Markets Mojo
Evoke Pharma Leads Six-Month Stock Returns with 298.55% Gain - Markets Mojo
Evoke Pharma Achieves 340% Return, Leading Recent Stock Performers - Markets Mojo
Evoke Pharma Leads Stock Returns with 121.77% Gain Over Past Year - Markets Mojo
Evoke Pharma Leads Stock Performance with 100.36% Return in Past Year - Markets Mojo
0.79%
자본화:
|
볼륨(24시간):